GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Glenmark Pharmaceuticals Ltd.

NSE: GLENMARK | BSE: 532296 | ISIN: INE935A01035 | Industry: Pharmaceuticals
| Mid-range Performer

1918.8000 -8.00 (-0.42%)

NSE Sep 02, 2025 15:31 PM

50.44% Gain from 52W Low

Volume: 253.3K

Glenmark Pharmaceuticals Ltd.

21 Sep 2023

1918.80

-0.42%

Company Update

GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Glenmark Pharma announces proposed Divestment of Majority Stake in Glenmark Life Sciences Limited

More from Glenmark Pharmaceuticals Ltd.

Recommended

Five stocks to buy from analysts this week - September 2, 2025

The Baseline | 02 Sep 2025, 06:04PM

Market closes lower, Trident to acquire a 30% stake in Trident Global for Rs 250 crore

Trendlyne Marketwatch | 02 Sep 2025, 04:00PM

Earnings Call Transcript - Q4FY20 for Glenmark Pharmaceuticals